Dr. Michelle Tarver said the FDA’s device center is filling positions after losing large numbers of clinical reviewers and AI ...
Medtronic said Monday it has received a CE mark for its Vitalis portfolio of cardiac pacemakers. The portfolio features five ...
ResMed CEO Mick Farrell, chair of AdvaMed’s board, said the group plans to come up with standards around privacy, ...
AI has become deeply embedded in clinical medical imaging. Specialized algorithms can now detect intracranial bleeds, measure ...
Edwards is asking customers to return some of the delivery systems used with its Sapien M3 devices after receiving three ...
Facing continued softness, Intuitive outlined opportunities to increase use of its robots in benign general surgeries.
MiniMed completed its separation from Medtronic, the companies said Thursday. The diabetes technology firm, which went public ...
At AdvaMed’s The MedTech Conference, company executives said they’re bracing for disruption by investing in inventory, ...
As the closely watched screening test moves closer to Food and Drug Administration approval, MedTech Dive asked cancer ...
Industry groups have worked to release guidance on artificial intelligence-backed agents in the absence of federal regulation.
With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the Type 2 population.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results